Huimei Technology is a technology company.
Huimei Technology has raised $99.0M across 3 funding rounds.
Huimei Technology has raised $99.0M in total across 3 funding rounds.
Huimei Technology has raised $99.0M in total across 3 funding rounds.
Huimei Technology's investors include 5Y Capital, Qiming Venture Partners.
Huimei Technology is a Chinese company specializing in the development and design of medical artificial intelligence (AI) solutions aimed at improving clinical quality. Their products leverage advanced AI techniques such as natural language processing and deep learning to provide real-time decision support to doctors, enhancing diagnostic accuracy and patient care. The company primarily serves healthcare providers by addressing challenges in clinical decision-making and healthcare management, contributing to better patient outcomes. Huimei Technology has demonstrated growth momentum with $30 million in total funding and recognition as a national high-tech enterprise in China[1][2][3][6].
Founded in 2015, Huimei Technology emerged from a vision to integrate AI into healthcare to elevate clinical quality and efficiency. While specific founders' details are not publicly highlighted, the company’s evolution reflects a focus on harnessing AI to automate and optimize healthcare processes, including the PDCA (Plan-Do-Check-Act) cycle in healthcare management. Early traction likely came from successful deployments of AI-powered diagnostic tools and clinical decision support systems that resonated with healthcare providers seeking to improve patient outcomes[1][2][6].
Huimei Technology rides the growing trend of AI adoption in healthcare, a sector increasingly driven by the need for precision medicine, efficiency, and improved patient outcomes. The timing aligns with global healthcare digitization and the rising demand for AI tools that can handle complex clinical data and support medical professionals. Market forces such as aging populations, healthcare cost pressures, and technological advances in AI favor Huimei’s solutions. By enhancing clinical quality through AI, Huimei contributes to the broader ecosystem by pushing forward the integration of intelligent systems in healthcare workflows, potentially influencing standards and practices in medical diagnostics and management[1][2][3][6].
Looking ahead, Huimei Technology is poised to expand its impact by deepening AI capabilities and broadening adoption across healthcare institutions. Trends such as personalized medicine, AI explainability, and integration with electronic health records will likely shape its product evolution. As regulatory frameworks for AI in healthcare mature, Huimei’s established presence and technological foundation position it well to influence clinical AI standards and scale internationally. Its continued growth will depend on maintaining technological leadership and demonstrating clear clinical value, reinforcing its role as a key player in the AI-driven transformation of healthcare.
Huimei Technology has raised $99.0M across 3 funding rounds. Most recently, it raised $28.0M Venture Round in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $28.0M Venture Round | 5Y Capital, Qiming Venture Partners | |
| Sep 1, 2023 | $41.0M Series D | 5Y Capital, Qiming Venture Partners | |
| Aug 1, 2019 | $30.0M Series C | 5Y Capital, Qiming Venture Partners |